Skip to Content
scroll

4DMedical Ltd (4DX)

4DX $1.55

20 MINUTE DELAYED

14 DAYS FREE ACCESS

Join Market Matters and get full access
to all our Opinion + Action

LEARN MORE

4DX $1.55

20 MINUTE DELAYED

TODAY

17.94 %

1 YEAR RETURN

0.00%

VOLUME

31,073,818

DIV YIELD

0%

PE RATIO

0.00

52 WEEK RANGE

0.23

1.76

ANALYSIS

i

SHARE PRICE ACTIVITY
Last (Price)

1.55

Change

0.24 (17.94)

Bid / Ask

1.54 - 1.56

Volume

31,073,818

Turnover

48,502,713

Open

1.40

Day Range

1.35 - 1.76

VWAP

1.56

Prev Close

1.31

Last Trade

05/09 4:19pm (AEST)

i

KEY INFORMATION
Sector

Healthcare

Shares Issued

373,933,497

NTA/Share

0.00

Last Dividend

0.00

Dividend Ex Date

0

Dividend Pay Date

0

i

BROKER CALLS

current

Mean

0.00

Target Price

0.00

i

CURRENT ()
Revenue

EBITDA

Profit

Earnings Per Share (EPS)

0

Dividend Per Share (DPS)

0

Yield %

0.00

Market Cap

0

Price to Earnings Ratio (P/E)

0

i

TARGET PRICE FORECAST

i

ESTIMATES ()
Revenue

0.00

EBITDA

0.00

Profit

0.00

Earnings Per Share (EPS)

0.00

Dividend Per Share (DPS)

0.00

i

BROKER CONSENSUS RECOMMENDATION

BUY

SELL

Target Price

0.00

Lt Growth Rate

0.00

Recommendation ()

0.00
image description

Business Summary

4DMedical Limited is an Australia-based medical technology company focused on delivering respiratory diagnostics for all lung disorders, including coronavirus, asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis and cancer. The Company's XV Technology is a four-dimensional lung imaging technology that utilizes mathematical models and algorithms to convert X-ray scans into quantitative data for physicians to manage patients with respiratory diseases and diseases of the lung. The XV Technology is accessible through a cloud-based software as a service (SaaS) platform that integrates with existing hospital equipment. The XV Technology Lung Ventilation Analysis Software (XV LVAS Ventilation) provides a non-invasive way of understanding regional lung motion and airflow. The Company's software enables physicians to detect areas of high and low ventilation from all parts of the lung, in all phases of the breath.

image description

Only available to Members

Take a free 14 day Market Matters trial – full access to all our reports, portfolios, positions, buy and sell recommendations. Access the latest views on the latest developments from professional money managers. It's free and no payment details are required
For membership options and pricing. Click here
Back to top